HK1058799A1 - Process for the preparation of 3-oxo-4-azasteroids. - Google Patents

Process for the preparation of 3-oxo-4-azasteroids.

Info

Publication number
HK1058799A1
HK1058799A1 HK04100269A HK04100269A HK1058799A1 HK 1058799 A1 HK1058799 A1 HK 1058799A1 HK 04100269 A HK04100269 A HK 04100269A HK 04100269 A HK04100269 A HK 04100269A HK 1058799 A1 HK1058799 A1 HK 1058799A1
Authority
HK
Hong Kong
Prior art keywords
azasteroids
oxo
preparation
compounds
ammonium
Prior art date
Application number
HK04100269A
Other languages
English (en)
Inventor
Roman Davis
Alan Millar
Jeffrey Thomas Sterbenz
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of HK1058799A1 publication Critical patent/HK1058799A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J75/00—Processes for the preparation of steroids in general
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Glass Compositions (AREA)
  • Iron Core Of Rotating Electric Machines (AREA)
  • Valve Device For Special Equipments (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK04100269A 2000-11-03 2004-01-14 Process for the preparation of 3-oxo-4-azasteroids. HK1058799A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0026876.3A GB0026876D0 (en) 2000-11-03 2000-11-03 Process
PCT/US2001/048173 WO2002046207A2 (en) 2000-11-03 2001-11-02 Process

Publications (1)

Publication Number Publication Date
HK1058799A1 true HK1058799A1 (en) 2004-06-04

Family

ID=9902484

Family Applications (1)

Application Number Title Priority Date Filing Date
HK04100269A HK1058799A1 (en) 2000-11-03 2004-01-14 Process for the preparation of 3-oxo-4-azasteroids.

Country Status (24)

Country Link
US (1) US6794508B2 (de)
EP (1) EP1335930B1 (de)
JP (1) JP4257117B2 (de)
KR (1) KR100821018B1 (de)
CN (1) CN1313480C (de)
AT (1) ATE279429T1 (de)
AU (2) AU4162402A (de)
BR (1) BR0115089A (de)
CA (1) CA2427709A1 (de)
DE (1) DE60106482T2 (de)
DK (1) DK1335930T3 (de)
ES (1) ES2230383T3 (de)
GB (1) GB0026876D0 (de)
HK (1) HK1058799A1 (de)
HU (1) HUP0303907A3 (de)
IL (2) IL155078A0 (de)
MX (1) MXPA03003925A (de)
NO (1) NO325180B1 (de)
NZ (1) NZ525168A (de)
PL (1) PL206539B1 (de)
PT (1) PT1335930E (de)
SI (1) SI1335930T1 (de)
WO (1) WO2002046207A2 (de)
ZA (1) ZA200302560B (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100503193B1 (ko) 2002-08-19 2005-07-25 한미약품 주식회사 3-옥소-4-아자-5α-안드로스탄 화합물의 선택적인 제조방법
WO2005075497A1 (en) * 2004-01-07 2005-08-18 Ranbaxy Laboratories Limited PROCESS FOR THE PREPARATION OF 17ß-SUBSTITUTED-3-OXO-4-AZA-5ALPHA-ANDROSTANE DERIVATIVES
CN100355772C (zh) * 2005-12-28 2007-12-19 天津大学 具有5α－还原酶抑制活性的甾体化合物及其制备方法
AR070313A1 (es) 2008-01-03 2010-03-31 Gador Sa Un procedimiento para preparar una forma solida y cristalina de dutasteride, una forma polimorfica del compuesto (forma iii) y una composicion farmaceutica que incluye dicha forma
HU230730B1 (hu) 2011-06-30 2017-12-28 Richter Gedeon Nyrt Eljárás (5alfa,17béta)-N-[2,5-bisz-(trifluormetil)-fenil]-3-oxo-4-aza-5-androszt-1-én-17-karbonsavamid előállítására
CN103059097A (zh) * 2011-10-20 2013-04-24 连云港润众制药有限公司 一种度他雄胺中间体的制备方法
CN103254268A (zh) * 2013-05-16 2013-08-21 寿光市富康化学工业有限公司 一种制备度他雄胺的工艺
CN104231033B (zh) * 2014-09-17 2016-08-24 广东众生药业股份有限公司 一种度他雄胺的制备方法
CN108051513B (zh) * 2017-11-27 2020-09-29 重庆华邦制药有限公司 Hplc法分离测定度他雄胺起始原料sm2及其相关杂质的方法
CN109438549B (zh) * 2018-12-13 2022-01-04 湖北葛店人福药业有限责任公司 一种制备N-叔丁基-3-氧代-4-氮杂-5α-雄甾-17β-甲酰胺的方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL74365A (en) 1984-02-27 1990-07-26 Merck & Co Inc 17beta-(n-t.-butylcarbamoyl)-4-aza-5alpha-androst-1-en-3-one and pharmaceutical compositions containing it
GB2264494A (en) * 1992-02-25 1993-09-01 Merck & Co Inc 17b-n-monosubstituted carbamoyl-11-oxo-4-aza-5-a-androst-1-en-3-one testosterone-5-alpha reductase inhibitors
TW408127B (en) * 1993-09-17 2000-10-11 Glaxo Inc Androstenones

Also Published As

Publication number Publication date
KR20030081326A (ko) 2003-10-17
PT1335930E (pt) 2005-01-31
HUP0303907A2 (hu) 2004-03-01
KR100821018B1 (ko) 2008-04-08
EP1335930A2 (de) 2003-08-20
PL365705A1 (en) 2005-01-10
ES2230383T3 (es) 2005-05-01
NO325180B1 (no) 2008-02-11
CA2427709A1 (en) 2002-06-13
IL155078A0 (en) 2003-10-31
US6794508B2 (en) 2004-09-21
HUP0303907A3 (en) 2012-09-28
MXPA03003925A (es) 2003-08-19
ATE279429T1 (de) 2004-10-15
IL155078A (en) 2009-06-15
BR0115089A (pt) 2003-10-07
JP2004515505A (ja) 2004-05-27
CN1313480C (zh) 2007-05-02
DK1335930T3 (da) 2005-02-14
WO2002046207A2 (en) 2002-06-13
EP1335930B1 (de) 2004-10-13
WO2002046207A3 (en) 2003-03-20
US20040049042A1 (en) 2004-03-11
NO20031995D0 (no) 2003-05-02
CN1473165A (zh) 2004-02-04
NZ525168A (en) 2005-03-24
ZA200302560B (en) 2004-04-01
GB0026876D0 (en) 2000-12-20
AU4162402A (en) 2002-06-18
NO20031995L (no) 2003-05-02
PL206539B1 (pl) 2010-08-31
DE60106482D1 (de) 2004-11-18
SI1335930T1 (en) 2005-04-30
AU2002241624B2 (en) 2004-10-28
DE60106482T2 (de) 2005-10-13
JP4257117B2 (ja) 2009-04-22

Similar Documents

Publication Publication Date Title
BRPI0113670B8 (pt) composição farmacêutica e método para tratar hipogonadismo
DE69726577D1 (en) Kristallin form i von clarithromycin
AU4162402A (en) Process
MY131522A (en) PHARMACEUTICAL COMPOSITION AND USES FOR ANDROST-5-ENE-3ß,17ß-DIOL
DE69828958D1 (de) Arzneiformulierungen zur hormonersatztherapie zur topischen anwendung auf der haut
PT1196414E (pt) Pro-farmacos de inibidores carbamato de impdh
NZ504423A (en) Composition having enhanced penetration capabilities and irritation reducing systems
AU2002239348A1 (en) Pyrazolopyridine derivatives
AU2001247968A1 (en) Use of asiatic acid or asiaticoside for treatment of cancer
GB0216001D0 (en) Process and composition
SI1347764T1 (sl) Gelni sestavek na alkoholni osnovi za zdravljenje hipogonadizma s trans-skrotalno aplikacijo
SE1212311T3 (de)
ZA985993B (en) Pharmaceutical compositions
AU2001231849A1 (en) Use of dehydroepiandrosterone and/or precursors or derivatives thereof to improve papery aspect of the skin
AU4621500A (en) Novel aluminosiloxane compound and process for preparing the same
WO2002072003A3 (en) Use of steroid derivatives for the treatment of a benighn and/or malignant tumour
AU2002227970A1 (en) Method for producing cis-2-tert-butylcyclohexanol
AU2001274138A1 (en) Propanolaminotetralines, preparation thereof and compositions containing same
ATE397615T1 (de) 6-o-alkyl-2-nor-2-substituierte ketolidderivate
AU2002215996A1 (en) Phenanthridine derivatives and antitumoral medicaments containing phenanthridine
DE50007708D1 (de) Ungesättigte 14,15-cyclopropano-androstane, verfahren zu ihrer herstellung und diese verbindungen enthaltende pharmazeutische zusammensetzungen
RS20060104A (en) Delta 15-d-homosteroids having an androgenic effect

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20121102